Authors
Loading...
Pharmacological targeting of PPAR-δ influences metastasis and metabolic response in pancreatic cancer, suggesting new treatment avenues.
Parejo-Alonso et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: